Changes in the Board of Directors

Changes in the Board of Directors

Altstätten, January 9, 2013 - COLTENE Holding AG (SIX Swiss Exchange: CLTN),
an internationally leading developer and producer of dental consumables,
announces today that its Board of Directors nominates Prof. Dr. med. dent.
Roland Weiger as a new Board member for election at the next ordinary Annual
General Meeting in April 2013. Prof. Roland Weiger is currently serving as
Professor and Director of the Periodontology, Endodontology and Cariology
Clinic at the University of Basel and Director of its Department of Dental
Medicine. The Board of Directors also announces that Jerry Sullivan, former
CEO and current Board Member of COLTENE, will not seek re-election at the end
of his current period of office in April 2013.

"I would like to sincerely thank Jerry Sullivan for his many years of valuable
contributions to COLTENE, as a member of management, as CEO and in recent
years as a Board Member. His profound knowledge of the dental market and the
COLTENE organisation has been of great benefit to COLTENE during his 30 years
of service with the Company," says Nick Huber, Chairman of the Board of
Directors of COLTENE Holding AG. "And I am very happy to propose Prof. Roland
Weiger as a new member to the Board of Directors. His profound knowledge of
dental procedures and special expertise in the area of restorative dentistry
will bring a high level of expertise to COLTENE's Board of Directors in a core
area of the Company."

Prof. Roland Weiger (born in1961 in Reutlingen, Germany) studied dentistry at
the Eberhard-Karls University in Tübingen, graduating summa cum laude in 1987.
He started his career in the Polyclinic for Dentistry in the Tooth, Mouth and
Jaw Centre at the University Clinic, Tübingen, where he became a Consultant
Dental Surgeon in 1996 and then Professor of Dentistry in Endodontology in
2000. In 2002 he was elected to his current position at the University of
Basel, a position which combines teaching, research and patient treatment
work. Prof. Weiger was Chairman of the Research Committee, European Society of
Endodontology (ESE) until 2012 and is currently President of the Expert
Commission of the Swiss Organisation for Preventative and Restorative medicine
(SVPR), a member of the Boards of the Swiss Society of Periodontology (SSP)
and the German Society for Endodontology and Dental Traumatology (DGET),
member of the Research Fund of the Society of Swiss Dentists (SSO) and
President of the Finance Committee of the Department of Dental Medicine,
University Basel.

The Board of Directors is confident that in proposing Prof. Roland Weiger as a
future Board Member to shareholders, it is proposing a person who will bring a
deep understanding of current dental methodology and practices and future
trends to the Company's governing body.

Sign-up for e-mail subscription is available at

For further information: Michael Düringer, Corporate Communications/Investor
phone +41 43 244 81 42, mobile +41 79 653 19 75, e-mail

Financial Calendar

Full-year Results 2012                 New date: March 8, 2013
Annual General Meeting of Shareholders New date: April 15, 2013
Half-year Report 2013                  August 15, 2013


COLTENE is an internationally leading developer, manufacturer and seller of
dental consumables and small equipment. COLTENE has state-of-the-art
production facilities in the USA, Switzerland, Germany, Hungary and Brazil.
Dentists and dental labs use COLTENE products for traditional as well as
implant-based therapies and dental reconstructions. The registered shares of
COLTENE Holding AG (CLTN) are listed on SIX Swiss Exchange. Learn more about
COLTENE and our products at

This press release and oral statements or other written statements made, or to
be made, by us contain forward-looking statements that do not relate solely to
historical or current facts. These forward-looking statements are based on the
current plans and expectations of our management and are subject to a number
of uncertainties and risks that could significantly affect our current plans
and expectations, as well as future results of operations and financial
condition. We undertake no obligation to publicly update or revise any
forward-looking statements, whether as a result of new information, future
events or otherwise.

Media Release (PDF)

Provider                  Channel         Contact
Tensid Ltd., Switzerland      Provider/Channel related enquiries   
                                          +41 41 763 00 50
Press spacebar to pause and continue. Press esc to stop.